AzTrials
AzTrials

Chronic PainNCT01752010

Comparing Acupuncture, BioModulator, and Transcutaneous Electrical Nerve Stimulation for Symptomatic Treatment of Chronic Pain.

A study testing Traditional Chinese Acupuncture, Tennant™ Biomodulator Treatment and Transcutaneous electrical nerve stimulation (TENS) Treatment in people with Chronic Pain and Depression, run by Samueli Institute for Information Biology at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary objective of this preliminary study is to compare the Tennant BioModulator with Transcutaneous Electrical Nerve Stimulation (TENS) and Traditional Chinese Acupuncture for the management of chronic pain among injured service members. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Chronic Pain, Depression, PTSD Symptoms
What is being tested?
Traditional Chinese Acupuncture, Tennant™ Biomodulator Treatment and Transcutaneous electrical nerve stimulation (TENS) Treatment
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
98 participants
Where
1 siteUnited States
Study dates
May 2010to Apr 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Subjects must be Injured service members between the ages of 18 and 60, inclusive;
  • The pain must have been present for 3 months or greater prior to entry into the study;
  • Subjects must agree to follow the medication regime as directed by the pain clinic provider for the duration of the study;
  • Subjects must be able to speak and read English and understand study procedures

Who cannot join

  • Epilepsy
  • Pregnancy, or considering pregnancy within the study time-frame
  • Pacemaker
  • History of cardiac arrhythmias
  • Implantable devices (AICD, pump, etc.)
  • Surgical intervention during the past month for the treatment of low back pain or its underlying etiology
Show all 9Show fewer
  • Documented history of prescription medication abuse
  • Abuse of illicit drugs within the last 6 months
  • Participation in a clinical trial for an investigational drug and/or agent within 30 days prior to screening

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Brooke Army Medical Center

    Fort Sam Houston, Texas, 78234

Other trials in United States

About this study

Official title: A Randomized Study Comparing the Tennant BioModulator to Transcutaneous Electrical Nerve Stimulation (TENS) and Traditional Chinese Acupuncture for the Symptomatic Treatment of Chronic Pain Among Injured Service Members.

The primary objective of this preliminary study is to compare the Tennant BioModulator with Transcutaneous Electrical Nerve Stimulation (TENS) and Traditional Chinese Acupuncture for the management of chronic pain among injured service members. The secondary objective is to investigate any associative effects or benefits on sleep, Post-Traumatic Stress Disorder (PTSD) symptoms, or depression.

Being tested
Traditional Chinese Acupuncture, Tennant™ Biomodulator Treatment, Transcutaneous electrical nerve stimulation (TENS) Treatment
Medical subject headings
Chronic Pain, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Traditional Chinese AcupunctureOther

    Treatment will be performed by an experienced provider, and may include insertion of sterile 32-gage (0.25mm) acupuncture needles on any part of the body that can be needled while the subject is lying prone with their head in a face cradle. The needles are usually retained for 20-30 minutes along various meridian points identified by the practitioner as being "blocked." Needles will be inserted to the depth typically recommended for the particular point of concern; generally 1 to 3cm. There are no constraints on the number of needles used. Acupuncture points are points of lower resistance and higher electrical conductance than the surrounding tissue. Placing the acupuncture needles into points identified as blocked is believed to help restore the flow of energy and stimulates the release of endorphins. The subject's level of pain is assessed on a 0-10 pain scale. Thirty minute acupuncture treatments will be given by the provider once a week for 6 weeks at the pain clinic.

  • Tennant™ Biomodulator TreatmentDevice

    An FDA-approved Tennant™ 650 BioModulator will be used to deliver electrical stimulation. The device will be applied directly on top of the subject's area of pain for one minute; power is adjusted until the subject feels a slight tingle. Random variations of pulse amplitude are set from zero to a chosen comfort limit. A feedback mechanism is provided by the constant monitoring of skin impedance. The device is then pressed onto the site of pain and rotated counter-clockwise. After a minute, the device is placed on the opposite side of the pain site and the procedure repeated. The subject's level of pain is assessed on a 0-10 pain scale. At no time is the level of electrical stimulation allowed to cause sustained pain. The subject will receive a weekly 15 minute visit that includes a treatment provided by the pain provider. The provider will teach the subject how to use the machine by themselves and instruct the subject to use the machine twice a day on their own during the study.

  • Transcutaneous electrical nerve stimulation (TENS) TreatmentDevice

    An FDA-approved Empi™ TENS unit will be used to deliver the transcutaneous electrical nerve stimulation. The low frequency TENS unit will be applied to the subject's area of pain by the use of four integrated self-adhering 5x5 cm electrodes. The electrodes will be positioned at a distance of 3 cm and centered over the area that is most painful. The device rapidly delivers therapeutic electrical currents at various frequencies off and on 150 times a second. The subject's level of pain is assessed on a 0-10 pain scale. At no time is the level of electrical stimulation allowed to cause sustained pain. The subject will receive a weekly 15 minute visit that includes a treatment provided by the pain provider. The provider will teach the subject how to use the machine by themselves and instruct the subject to use the machine twice a day on their own during the study.

Study groups in NCT01752010
Study groupRoleWhat they receive
Acupuncture TreatmentActive comparatorTraditional Chinese acupuncture.
Receives: Other: Traditional Chinese Acupuncture
Tennant™ Biomodulator TreatmentActive comparatorNot described
Receives: Device: Tennant™ Biomodulator Treatment
Transcutaneous electrical nerve stimulation (TENS) TreatmentActive comparatorNot described
Receives: Device: Transcutaneous electrical nerve stimulation (TENS) Treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Chronic pain

    Measured: Baseline; post-intervention; one-month follow up.

Secondary outcomes (1)
  1. Depression, PTSD symptoms, Sleep.

    Measured: Baseline; post-intervention; one-month follow up.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Dec 2012 (estimated)
  2. Study startMay 2010
  3. Primary completionApr 2014
  4. Study completionApr 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
98 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01752010
Sponsor's protocol ID
C.2009.098
Status last verified
May 2015
First submitted
14 Dec 2012
Last updated
19 May 2015
Results posted
No
Data monitoring committee
Yes

Publications

  • Peacock KS, Stoerkel E, Libretto S, Zhang W, Inman A, Schlicher M, Cowsar JD Jr, Eddie D, Walter J. A randomized trial comparing the Tennant Biomodulator to transcutaneous electrical nerve stimulation and traditional Chinese acupuncture for the treatment of chronic pain in military service members. Mil Med Res. 2019 Dec 2;6(1):37. doi: 10.1186/s40779-019-0227-4.

    PubMed 31791416

Questions about this trial

What is this clinical trial studying?

A study testing Traditional Chinese Acupuncture, Tennant™ Biomodulator Treatment and Transcutaneous electrical nerve stimulation (TENS) Treatment in people with Chronic Pain and Depression, run by Samueli Institute for Information Biology at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 May 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Chronic pain (time frame: Baseline; post-intervention; one-month follow up.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01752010, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT01752010 | AzTrials